Literature DB >> 15114675

Expression of milk fat globule epidermal growth factor 8 in immature dendritic cells for engulfment of apoptotic cells.

Kay Miyasaka1, Rikinari Hanayama, Masato Tanaka, Shigekazu Nagata.   

Abstract

Milk fat globule epidermal growth factor 8 (MFG-E8) is a protein that stimulates the engulfment of apoptotic cells by phagocytes. Here, we show that mouse immature dendritic cells (DC) generated in vitro by culturing bone marrow progenitors in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), and Langerhans cells present in the skins, expressed MFG-E8. Bone marrow-derived macrophages generated by M-CSF did not express MFG-E8. MFG-E8 expressed in immature DC was found to be secreted as exosomes. The expression of MFG-E8 was significantly suppressed when the immature DC were induced to mature by treating them with lipopolysaccharides. This expression of MFG-E8 was well correlated with the ability of the cells to engulf apoptotic cells. That is,immature DC phagocytosed apoptotic cells more efficiently than did mature DC or bone marrow-derived macrophages. The ability of immature DC to engulf apoptotic cells was severely reduced when the immature DC were prepared from MFG-E8-deficient mice. These results indicated that MFG-E8 plays an essential role in the engulfment of apoptotic cells by bone marrow-derived immature DC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114675     DOI: 10.1002/eji.200424930

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  37 in total

Review 1.  Exosomes: immune properties and potential clinical implementations.

Authors:  Nathalie Chaput; Clotilde Théry
Journal:  Semin Immunopathol       Date:  2010-12-21       Impact factor: 9.623

Review 2.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

3.  MFG-E8 expression for progression of oral squamous cell carcinoma and for self-clearance of apoptotic cells.

Authors:  Manabu Yamazaki; Satoshi Maruyama; Tatsuya Abé; Ahmed Essa; Hamzah Babkair; Jun Cheng; Takashi Saku
Journal:  Lab Invest       Date:  2014-09-29       Impact factor: 5.662

4.  Pericyte-derived MFG-E8 regulates pathologic angiogenesis.

Authors:  Sei-ichiro Motegi; Wolfgang W Leitner; Michael Lu; Yayoi Tada; Miklós Sárdy; Chuanjin Wu; Triantafyllos Chavakis; Mark C Udey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-07       Impact factor: 8.311

5.  Recombinant human milk fat globule-EGF factor 8 produces dose-dependent benefits in sepsis.

Authors:  Kavin G Shah; Rongqian Wu; Asha Jacob; Ernesto P Molmenti; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Intensive Care Med       Date:  2011-09-23       Impact factor: 17.440

Review 6.  Role of milk fat globule-epidermal growth factor 8 in osteoimmunology.

Authors:  Kathrin Sinningen; Sylvia Thiele; Lorenz C Hofbauer; Martina Rauner
Journal:  Bonekey Rep       Date:  2016-07-20

Review 7.  Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.

Authors:  Thomas S Griffith; Thomas A Ferguson
Journal:  Immunity       Date:  2011-10-28       Impact factor: 31.745

8.  MFG-E8 regulates microglial phagocytosis of apoptotic neurons.

Authors:  Abby D Fuller; Linda J Van Eldik
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-01       Impact factor: 4.147

Review 9.  TRAIL gene therapy: from preclinical development to clinical application.

Authors:  Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian
Journal:  Curr Gene Ther       Date:  2009-02       Impact factor: 4.391

10.  Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.

Authors:  Masahisa Jinushi; Marimo Sato; Akira Kanamoto; Akihiko Itoh; Shigenori Nagai; Shigeo Koyasu; Glenn Dranoff; Hideaki Tahara
Journal:  J Exp Med       Date:  2009-05-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.